2022 annual financial data
Cumberland Pharmaceuticals 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was 20.12%.
Operating income was -5,704,929 USD and net income was -5,570,241 USD.
Operating cash flow was 8,453,396 USD.
Get free Cumberland Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42,010,949 USD
- Operating income
- -5,704,929 USD
- Net income
- -5,570,241 USD
- Operating cash flow
- 8,453,396 USD